tradingkey.logo

Amneal Pharmaceuticals Inc

AMRX
14.520USD
-0.250-1.69%
종가 02/06, 16:00ET시세는 15분 지연됩니다
4.56B시가총액
814.81P/E TTM

Amneal Pharmaceuticals Inc

14.520
-0.250-1.69%

자세한 내용은 Amneal Pharmaceuticals Inc 회사

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Inc 정보

종목 코드 AMRX
회사 이름Amneal Pharmaceuticals Inc
상장일Nov 18, 2009
CEOPatel (Chintu)
직원 수8100
유형Ordinary Share
회계 연도 종료Nov 18
주소400 Crossing Boulevard, 3rd Floor
도시BRIDGEWATER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호08807
전화19089473120
웹사이트https://amneal.com/
종목 코드 AMRX
상장일Nov 18, 2009
CEOPatel (Chintu)

Amneal Pharmaceuticals Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-151332.00%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+151496.00%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+40258.00%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+40258.00%
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
25.62M
--
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-151332.00%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+151496.00%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+40258.00%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
191.40K
--
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+40258.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
기타
263.51M
33.59%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
기타
263.51M
33.59%

주식 보유 통계

마지막 업데이트: Sun, Jan 11
마지막 업데이트: Sun, Jan 11
주주
주주 유형
주주
주주
비율
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
기타
55.24%
주주
주주
비율
Patel (Tushar Bhikhubhai)
15.45%
Patel (Chintu)
8.15%
Patel (Dipan)
7.58%
Patel (Chirag K)
7.04%
Akram (Mahesh)
6.54%
기타
55.24%
주주 유형
주주
비율
Individual Investor
46.38%
Investment Advisor
19.73%
Investment Advisor/Hedge Fund
12.11%
Hedge Fund
11.57%
Private Equity
3.92%
Research Firm
1.93%
Pension Fund
0.28%
Bank and Trust
0.18%
Family Office
0.03%
기타
3.87%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
2023Q3
338
82.03M
56.21%
+4.32M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Patel (Tushar Bhikhubhai)
48.58M
15.45%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
25.62M
8.15%
--
--
Oct 03, 2025
Patel (Dipan)
23.83M
7.58%
--
--
Oct 03, 2025
Patel (Chirag K)
22.13M
7.04%
--
--
Aug 06, 2025
Akram (Mahesh)
20.56M
6.54%
-6.30M
-23.45%
Mar 31, 2025
The Vanguard Group, Inc.
17.90M
5.69%
+403.58K
+2.31%
Sep 30, 2025
Rubric Capital Management LP
12.33M
3.92%
+624.61K
+5.33%
Sep 30, 2025
TPG Capital, L.P.
12.33M
3.92%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.34M
3.61%
+697.25K
+6.55%
Sep 30, 2025
Citadel Advisors LLC
5.73M
1.82%
+104.62K
+1.86%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
더 보기
Invesco Pharmaceuticals ETF
비율3.08%
State Street SPDR S&P Pharmaceuticals ETF
비율2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율2%
Invesco Dorsey Wright Healthcare Momentum ETF
비율0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
비율0.83%
First Trust NASDAQ Pharmaceuticals ETF
비율0.78%
First Trust Small Cap Growth AlphaDEX Fund
비율0.72%
iShares U.S. Pharmaceuticals ETF
비율0.68%
ProShares Ultra Nasdaq Biotechnology
비율0.48%
WisdomTree US SmallCap Fund
비율0.36%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI